1. Arnold, M, Soerjomataram, I, Ferlay, J, et al. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 2015; 64: 381–387.
Google Scholar | Crossref | Medline2. Bray, F, Ferlay, J, Soerjomataram, I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424.
Google Scholar | Crossref | Medline3. Lee, GD, Kim, YH, Kim, JB, et al. Esophageal cancer associated with multiple primary cancers: Surgical approaches and long-term survival. Ann Surg Oncol 2013; 20: 4260–4266.
Google Scholar | Crossref | Medline4. Kagei, K, Hosokawa, M, Shirato, H, et al. Efficacy of intense screening and treatment for synchronous second primary cancers in patients with esophageal cancer. Jpn J Clin Oncol 2002; 32: 120–127.
Google Scholar | Crossref | Medline5. van Putten, M, de Vos-Geelen, J, Nieuwenhuijzen, GAP, et al. Long-term survival improvement in oesophageal cancer in the Netherlands. Eur J Cancer 2018; 94: 138–147.
Google Scholar | Crossref | Medline6. Lee, JS, Ahn, JY, Choi, KD, et al. Synchronous second primary cancers in patients with squamous esophageal cancer: Clinical features and survival outcome. Korean J Intern Med 2016; 31: 253–259.
Google Scholar | Crossref | Medline7. Slaughter, DP, Southwick, HW, Smejkal, W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963–968.
Google Scholar | Crossref | Medline | ISI8. Henry, MA, Lerco, MM, Naresse, LE, et al. Outcome of superficial squamous cell carcinoma of the esophagus: A clinicopathological study. Acta Cir Bras 2013; 28: 373–378.
Google Scholar | Crossref | Medline9. Abiko, S, Shimizu, Y, Miyamoto, S, et al. Risk assessment of metachronous squamous cell carcinoma after endoscopic resection for esophageal carcinoma based on the genetic polymorphisms of alcoholdehydrogense-1B aldehyde dehydrogenase-2: Temperance reduces the risk. J Gastroenterol 2018; 53: 1120–1130.
Google Scholar | Crossref | Medline10. Utada, M, Ohno, Y, Hori, M, et al. Incidence of multiple primary cancers and interval between first and second primary cancers. Cancer Sci 2014; 105: 890–896.
Google Scholar | Crossref | Medline | ISI11. Kumagai, Y, Kawano, T, Nakajima, Y, et al. Multiple primary cancers associated with esophageal carcinoma. Surg Today 2001; 31: 872–876.
Google Scholar | Crossref | Medline12. Zhu, G, Chen, Y, Zhu, Z, et al. Risk of second primary cancer after treatment for esophageal cancer: A pooled analysis of nine cancer registries. Dis Esophagus 2012; 25: 505–511.
Google Scholar | Crossref | Medline13. Natsugoe, S, Matsumoto, M, Okumura, H, et al. Multiple primary carcinomas with esophageal squamous cell cancer: Clinicopathologic outcome. World J Surg 2005; 29: 46–49.
Google Scholar | Crossref | Medline14. Mitani, S, Kadowaki, S, Oze, I, et al. Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis. Cancer Med 2020; 9: 394–400.
Google Scholar | Crossref | Medline15. Chuang, SC, Hashibe, M, Scelo, G, et al. Risk of second primary cancer among esophageal cancer patients: A pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev 2008; 17: 1543–1549.
Google Scholar | Crossref | Medline16. American Joint Committee on Cancer. AJCC cancer staging manual. 5th ed. Philadelphia/New York: Lippincott-Raven, 1997, p.294.
Google Scholar17. American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. New York: Springer, 2002.
Google Scholar18. American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York: Springer, 2010.
Google Scholar | Crossref19. Warren, S, Gates, O . Multiple primary malignant tumors: A survey of the literature and statistical study. Am J Cancer 1932; 51: 1358–1414.
Google Scholar20. Bugter, O, van de Ven, SEM, Hardillo, JA, et al. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis. Head Neck 2019; 41: 1122–1130.
Google Scholar | Crossref | Medline21. Bugter, O, van Iwaarden, DLP, Dronkers, EAC, et al. Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable. Head Neck 2019; 41: 1648–1655.
Google Scholar | Crossref | Medline22. van de Ven, SEM, Bugter, O, Hardillo, JA, et al. Screening for head and neck second primary tumors in patients with esophageal squamous cell cancer: A systematic review and meta-analysis. United European Gastroenterol J 2019; 7: 1304–1311.
Google Scholar | SAGE Journals | ISI23. Nagasawa, S, Onda, M, Sasajima, K, et al. Multiple primary malignant neoplasms in patients with esophageal cancer. Dis Esophagus 2000; 13: 226–230.
Google Scholar | Crossref | Medline24. Levi, F, Randimbison, L, Maspoli, M, et al. Second neoplasms after oesophageal cancer. Int J Cancer 2007; 121: 694–697.
Google Scholar | Crossref | Medline25. Ribeiro Junior, U, Cecconello, I, Safatle-Ribeiro, AV, et al. Squamous cell carcinoma of the esophagus and multiple primary tumors of the upper aerodigestive tract. Arq Gastroenterol 1999; 36: 195–200.
Google Scholar | Crossref | Medline26. Jemal, A, Bray, F, Center, MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
Google Scholar | Crossref | Medline | ISI27. Yokokawa, Y, Ohta, S, Hou, J, et al. Ecological study on the risks of esophageal cancer in Ci-Xian, China: The importance of nutritional status and the use of well water. Int J Cancer 1999; 83: 620–624.
Google Scholar | Crossref | Medline28. Li, H, Borinskaya, S, Yoshimura, K, et al. Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant. Ann Hum Genet 2009; 73: 335–345.
Google Scholar | Crossref | Medline | ISI29. Higuchi, S, Matsushita, S, Murayama, M, et al. Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiatry 1995; 152: 1219–1221.
Google Scholar | Crossref | Medline30. Chen, SC, Teng, CJ, Hu, YW, et al. Secondary primary malignancy risk among patients with esophageal cancer in Taiwan: A nationwide population-based study. PLoS One 2015; 10: e0116384.
Google Scholar | Medline31. Matsubara, T, Yamada, K, Nakagawa, A. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003; 21: 4336–4341.
Google Scholar | Crossref | Medline32. Hu, WS, Liu, ZJ, Zhang, JB, et al. Risk patterns of subsequent primary cancers following esophagectomy in early-stage thoracic esophageal squamous cell cancer patients. Tumori 2015; 101: 328–333.
Google Scholar | SAGE Journals33. van de Ven, SEM, Koch, AD. When is Lugol still necessary in 2020? Endosc Int Open 2020; 8: E1478–E1480.
Google Scholar34. Morimoto, H, Yano, T, Yoda, Y, et al. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23: 1051–1058.
Google Scholar | Crossref | Medline